🇮🇳IN
Sign In
CO

COHANCE

NSE

Cohance Lifesciences Limited

₹481.35

+5.30(+1.11%)

Ownership Score

Index Membership

and the weight we carry

Mutual Fund Ownership

% of each scheme's portfolio

Insider & Deals

who traded, and how close they are to the company

Ownership & Influence

who holds it, and what else they hold

Shared directors

companies with a board member in common

COHANCE shareholding summary

As of Jun 2026, promoters held 57.49% of Cohance Lifesciences Limited. Institutions together held 26.59%, of which foreign institutional investors held 6.50% (up 0.91 points from Mar 2026) and domestic institutions held 20.09% (down 1.70 points from Mar 2026). The public held the remaining 15.92% (up 0.81 points from Mar 2026). The company had 99,149 shareholders.

Promoters57.49%
FII6.50%
DII20.09%
Public15.92%

Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Disclaimer